Global Leadless Pacemakers Market By Overview
Prophecy Market Insights has recently published its insights on “Global Leadless Pacemakers Market” for the forecast period of 2018-2029. The market is segmented By Technology (Single Chambered, Subcutaneous ICD Leadless Pacing, Double Chambered, and Other), By End-user (Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers, and Others), and By Region
Rise in the geriatric population suffering from cardiovascular disorders is the major factor driving the growth of the global leadless pacemaker market. For instance, in 2017, according to key facts presented by World health Organization, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. In addition, technological advancement with rise in the investment in the healthcare segment is also propelling the growth of the target market. Also, lead is a toxic material which is not preferred to be used for making pacemaker, therefore boosting the global market growth. Moreover, these leadless pacemaker show no postoperative mobility restriction which is expected to fuel the target market growth during the forecast period. However, high cost of installment is the major factor restraining the growth of the global market.
North America to grow at the highest CAGR during the forecast period
The growth of the global leadless pacemaker market is highest in terms of revenue in North America region. This can be attributed to high prevalence of cardiovascular disorders in this region. Also, presence of key market players in this region is also boosting the global market growth. Europe is expected to follow North America in terms of revenue, whereas, Asia-Pacific is expected to show significant growth in the global market. This is due to increase in the cardiovascular disorders among people in this region. With this, increase in the investment in the healthcare sector by the government is also anticipated to boost the growth of the global market in the upcoming years.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
The global leadless pacemakers market report segments the market on the basis of technology, end user, and region.
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the global leadless pacemakers market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economical factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Competitive Analysis
Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global leadless pacemakers market. Key players have adopted mergers & acquisitions and new product developments to strengthen their positions in the leadless pacemakers market. For instance, Micra Trans-catheter Pacing System (TPS) pacemaker by Medtronic’s received the U.S. FDA approval in April 2016.
- Jude Medical LLC (Abbott Laboratories)
- Biotronic Inc.
- Boston Scientific
- Edwards Lifesciences
- Sorin Group
- Vitatron Holdings
- Lepu Medical
- Terumo Corp.
Prophecy Market Insights offers required customization on this report according to specific business requirements.
FAQs
The leadless pacemakers market report segments the market on the basis of technology, end user, and region.
The development of smaller and more advanced leadless pacemaker technologies, increased adoption of magnetic resonance imaging (MRI)-compatible devices, and the growing demand for less invasive cardiac pacing options, presenting significant opportunities in the global Leadless Pacemakers Market.
Rising incidence of cardiac arrhythmias and heart rhythm disorders, advancements in pacemaker technology, the demand for devices with fewer complications and infections, and the preference for leadless pacemakers in certain patient populations.
North America is expected to dominate the Leadless Pacemakers Market, driven by a well-established healthcare system, high prevalence of cardiovascular diseases, and significant adoption of innovative medical technologies in the region.
Jude Medical LLC (Abbott Laboratories), Biotronic Inc., Boston Scientific, Edwards Lifesciences, Sorin Group, Vitatron Holdings, Lepu Medical, Terumo Corp.,